These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 25032265)
1. Influence of regular physical activity on warfarin dose and risk of hemorrhagic complications. Shendre A; Beasley TM; Brown TM; Hill CE; Arnett DK; Limdi NA Pharmacotherapy; 2014 Jun; 34(6):545-54. PubMed ID: 25032265 [TBL] [Abstract][Full Text] [Related]
2. Race-Specific Influence of CYP4F2 on Dose and Risk of Hemorrhage Among Warfarin Users. Shendre A; Brown TM; Liu N; Hill CE; Beasley TM; Nickerson DA; Limdi NA Pharmacotherapy; 2016 Mar; 36(3):263-72. PubMed ID: 26877068 [TBL] [Abstract][Full Text] [Related]
3. Influence of Age on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage. Shendre A; Parmar GM; Dillon C; Beasley TM; Limdi NA Pharmacotherapy; 2018 Jun; 38(6):588-596. PubMed ID: 29393514 [TBL] [Abstract][Full Text] [Related]
4. Influence of warfarin dose-associated genotypes on the risk of hemorrhagic complications in Chinese patients on warfarin. Ma C; Zhang Y; Xu Q; Yang J; Zhang Y; Gao L; Xu B; Wang H; Li Y; Lu C; Yin T Int J Hematol; 2012 Dec; 96(6):719-28. PubMed ID: 23104259 [TBL] [Abstract][Full Text] [Related]
5. Influence of Kidney Transplant Status on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage. Yanik MV; Irvin MR; Beasley TM; Jacobson PA; Julian BA; Limdi NA Pharmacotherapy; 2017 Nov; 37(11):1366-1373. PubMed ID: 28949423 [TBL] [Abstract][Full Text] [Related]
6. Influence of kidney function on risk of supratherapeutic international normalized ratio-related hemorrhage in warfarin users: a prospective cohort study. Limdi NA; Nolin TD; Booth SL; Centi A; Marques MB; Crowley MR; Allon M; Beasley TM Am J Kidney Dis; 2015 May; 65(5):701-9. PubMed ID: 25468385 [TBL] [Abstract][Full Text] [Related]
7. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation. Hylek EM; Chang YC; Skates SJ; Hughes RA; Singer DE Arch Intern Med; 2000 Jun; 160(11):1612-7. PubMed ID: 10847254 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of warfarin therapy managed by pharmacists via hospital anticoagulation clinic versus online anticoagulation clinic. Cao H; Wu J; Zhang J Int J Clin Pharm; 2018 Oct; 40(5):1072-1077. PubMed ID: 29956134 [TBL] [Abstract][Full Text] [Related]
9. Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin. Hylek EM; Regan S; Go AS; Hughes RA; Singer DE; Skates SJ Ann Intern Med; 2001 Sep; 135(6):393-400. PubMed ID: 11560452 [TBL] [Abstract][Full Text] [Related]
10. Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series. Schultz KT; Bungard TJ Pharmacotherapy; 2011 Aug; 31(8):793-805. PubMed ID: 21923606 [TBL] [Abstract][Full Text] [Related]
11. [INTERNATIONAL NORMALIZED RATIO VALUES AND HEMORRHAGE IN HOSPITALIZED PATIENTS STARTING WARFARIN THERPY: AN OBSERVATIONAL STUDY]. Abadi U; Ellis MH Harefuah; 2015 Aug; 154(8):490-3, 541-2. PubMed ID: 26480611 [TBL] [Abstract][Full Text] [Related]
12. Prevalent aetiologies of non-therapeutic warfarin anticoagulation in a network of pharmacist-managed anticoagulation clinics. Cryder B; Felczak M; Janociak J; Dela Pena L; Allen S; Gutierrez P J Clin Pharm Ther; 2011 Feb; 36(1):64-70. PubMed ID: 21198721 [TBL] [Abstract][Full Text] [Related]
13. Acetaminophen and other risk factors for excessive warfarin anticoagulation. Hylek EM; Heiman H; Skates SJ; Sheehan MA; Singer DE JAMA; 1998 Mar; 279(9):657-62. PubMed ID: 9496982 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study. Bussey HI; Bussey M; Bussey-Smith KL; Frei CR Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412 [TBL] [Abstract][Full Text] [Related]
15. An analysis of the relative effects of VKORC1 and CYP2C9 variants on anticoagulation related outcomes in warfarin-treated patients. Meckley LM; Wittkowsky AK; Rieder MJ; Rettie AE; Veenstra DL Thromb Haemost; 2008 Aug; 100(2):229-39. PubMed ID: 18690342 [TBL] [Abstract][Full Text] [Related]
16. Genetic influence on bleeding and over-anticoagulation risk in patients undergoing warfarin treatment after heart valve replacements. Zhou L; Ding Y; Gao Y; Yang B; Bao J; Ma J Expert Opin Drug Metab Toxicol; 2020 Jan; 16(1):1-9. PubMed ID: 31914334 [No Abstract] [Full Text] [Related]
17. Warfarin-antibiotic interactions in older adults of an outpatient anticoagulation clinic. Ghaswalla PK; Harpe SE; Tassone D; Slattum PW Am J Geriatr Pharmacother; 2012 Dec; 10(6):352-60. PubMed ID: 23089199 [TBL] [Abstract][Full Text] [Related]
18. Oral anticoagulation and hemorrhagic complications in an elderly population with atrial fibrillation. Copland M; Walker ID; Tait RC Arch Intern Med; 2001 Sep; 161(17):2125-8. PubMed ID: 11570942 [TBL] [Abstract][Full Text] [Related]
19. Effect of Left Ventricular Systolic Dysfunction on Response to Warfarin. Ather S; Shendre A; Beasley TM; Brown T; Hill CE; Prabhu SD; Limdi NA Am J Cardiol; 2016 Jul; 118(2):232-6. PubMed ID: 27241839 [TBL] [Abstract][Full Text] [Related]
20. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation. Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]